September 28, 2022

AGD Applauds FDA Plans to Reduce Nicotine in Tobacco Products

  • by AGD Washington Advocacy Representative
  • Sep 14, 2022
AGD joined Tobacco Free Kids and over 70 other health, medical, education, and community organizations in a letter to Dr. Robert Califf, Commissioner of the Food and Drug Administration (FDA), to express support for the FDA’s recent announcement to develop a product standard that reduces nicotine levels in cigarettes to non-addictive or minimally addictive levels. The FDA says the goal of developing such a standard is to reduce youth use, addiction, and death.

The FDA projects that by year 2100, a potential nicotine product standard could result in more than 33 million people not becoming regular smokers, a smoking rate of only 1.4%, and more than 8 million fewer people dying from tobacco-related illnesses. The current smoking rate is 12.5%.

In their letter to the Commissioner, the undersigned write that, “reducing nicotine in cigarettes and other combusted tobacco products will complement FDA’s proposed rules to prohibit menthol cigarettes and flavored cigars,” and allow FDA to, “target both what attracts youth to these products and what addicts them.” The organizations urged the agency to move quickly to complete the rulemaking process.

Impact on General Dentistry: The AGD supports evidence-based policies that seek to effectively reduce tobacco use, particularly among adolescents and young adults. The link between tobacco use, disease, and adverse oral health conditions is well-founded.